Jad Fakhry, 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY), bought 48,930 shares at $0.62 ($30K) on 2025-02-25, disclosed to the SEC on 2025-04-15.
Open-market purchase of $30k NBY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 25,033 | $16K | 52.0% |
| 2 | $0.61 | 6,302 | $4K | 12.9% |
| 3 | $0.61 | 385 | $235 | 0.8% |
| 4 | $0.60 | 13,108 | $8K | 26.4% |
| 5 | $0.58 | 4,000 | $2K | 7.8% |
| 6 | $0.55 | 102 |
| $56 |
| 0.2% |
| Total | $0.61 avg | 48,930 | $30K | 100% |
| Filing → |
| NBY | BUY | 2025-04-15 | $16K | — | Filing → |
| SWSH | BUY | 2016-05-17 | $97K | — | Filing → |